ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Human Hypertension

• Publication date

  1992-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 1629885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• The Mystery of Diabetic Cardiomyopathy: From Early Concepts and Underlying Mechanisms to Novel Therapeutic Possibilities

  2021cites this paper
• Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme.

  2019cites this paper
• [Sar1, Ile4, Ile8]‐angiotensin II Potentiates Insulin Receptor Signalling and Glycogen Synthesis in Hepatocytes

  2018cites this paper
• SII Ang II Potentiates Insulin Receptor Signalling and Glycogen Synthesis in Hepatocytes

  2017cites this paper
• A bioluminescence resonance energy transfer 2 (BRET2) assay for monitoring seven transmembrane receptor and insulin receptor crosstalk

  2017cites this paper
• Pathophysiology of diabetes in older people

  2017cites this paper
• Pathophysiological Mechanisms and Correlates of Therapeutic Pharmacological Interventions in Essential Arterial Hypertension.

  2016cites this paper
• Regulation of pancreatic beta-cell function by the renin-angiotensin system in type 2 diabetes

  2015cites this paper
• Insulin Receptor Substrate-2 (Irs2) in Endothelial Cells Plays a Crucial Role in Insulin

  2015cites this paper
• Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.

  2014cites this paper
• Insulin Receptor Substrate-2 (Irs2) in Endothelial Cells Plays a Crucial Role in Insulin Secretion

  2014cites this paper
• The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.

  2013cites this paper
• insulin action in obese Zucker rats Interactions of exercise training and ACE inhibition on

  2013cites this paper
• The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity.

  2013cites this paper
• The Renin-Angiotensin System in the Pathophysiology of Type 2 Diabetes

  2012cites this paper
• Pathophysiologic therapeutic targets in hypertension: a cardiological point of view

  2012cites this paper
• Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System

  2012cites this paper
• The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome.

  2012cites this paper
• Formulary Management of ACE Inhibitors

  2012cites this paper
• The Role of the Angiotensin System in Cardiac Glucose Homeostasis

  2012cites this paper
• The Effect of Quinapril Treatment on Insulin Resistance, Leptin and High Sensitive C-Reactive Protein in Hypertensive Patients

  2011cites this paper
• The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis.

  2010cites this paper
• Aging-associated insulin resistance predisposes to hypertension and its reversal by exercise: the role of vascular vasorelaxation to insulin

  2009cites this paper
• Effect of renin angiotensin system inhibition on cardiovascular sequelae in elderly hypertensive patients with insulin resistance

  2009cites this paper
• Antihypertensive Effect of Sardine Peptide and Valy 1-Tyrosine in Spontaneously Hypertensive Rats

  2009cites this paper
• Introduction to Diabetes in Older People

  2008cites this paper
• Low glycaemic index diet and disposition index in type 2 diabetes (the Canadian trial of Carbohydrates in Diabetes): a randomised controlled trial

  2008cites this paper
• Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus

  2008cites this paper
• Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records

  2007cites this paper
• Patients with dilated cardiomyopathy possess insulin resistance independently of cardiac dysfunction or serum tumor necrosis factor-alpha.

  2006cites this paper
• Diabetes in the elderly.

  2006cites this paper
• Treatment of Spontaneously Hypertensive Rats With Rosiglitazone and/or Enalapril Restores Balance Between Vasodilator and Vasoconstrictor Actions of Insulin With Simultaneous Improvement in Hypertension and Insulin Resistance

  2006cites this paper
• [Angiotensin converting enzyme inhibitors in prevention and treatment of vascular complications of diabetes].

  2005cites this paper
• Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm.

  2005cites this paper
• A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive 2

  2005cites this paper
• The renin angiotensin system as a therapeutic target to prevent diabetes and its complications.

  2005cites this paper
• A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive

  2005cites this paper
• Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes.

  2005cites this paper
• Cardiovascular Pharmacogenetics

  2004cites this paper
• Insulin Resistance and Cardiovascular Disease: New Insights from Genetics

  2004cites this paper
• Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition

  2004cites this paper
• Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients

  2004cites this paper
• The kallikrein‐kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity

  2004cites this paper
• Effect of amlodipine on insulin resistance & tumor necrosis factor-alpha levels in hypertensive obese type 2 diabetic patients.

  2004cites this paper
• Effect of cilnidipine on insulin sensitivity in patients with essential hypertension.

  2003cites this paper
• Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition

  2003cites this paper
• Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance

  2003cites this paper
• Captopril enhanced insulin-stimulated glycogen synthesis in skeletal muscle but not fatty acid synthesis in adipose tissue of hereditary hypertriglyceridemic rats.

  2003cites this paper
• Drug Interactions with Angiotensin Receptor Blockers: A Comparison with Other Antihypertensives

  2003cites this paper
• Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.

  2003cites this paper
• Metabolic effects of antihypertensive treatment: long live the debate.

  2003cites this paper
• Possible involvement of the adipose tissue renin‐angiotensin system in the pathophysiology of obesity and obesity‐related disorders

  2003cites this paper
• Obesity and Type-2 Diabetes in the Elderly

  2003cites this paper
• Differentiation of the metabolic and vascular effects of insulin in insulin resistance in patients with chronic heart failure.

  2002cites this paper
• ACE Inhibitor Improves Insulin Resistance in Diabetic Mouse Via Bradykinin and NO

  2002cites this paper
• Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?

  2002cites this paper
• Retinal and Choroidal Vasculature in Rats with Spontaneous Diabetes Type 2 Treated with the Angiotensin-Converting Enzyme Inhibitor Cilazapril: Corrosion Cast and Electron-Microscopic Study

  2002cites this paper
• Regression of Left Ventricular Mass with Captopril and Metoprolol, and the Effects on Glucose and Lipid Metabolism

  2001cites this paper
• Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake

  2001cites this paper
• Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women.

  2001cites this paper
• The choice of first-line therapy: rationale for low-dose combinations of an angiotensin converting enzyme inhibitor and a diuretic.

  2001cites this paper
• Selective Angiotensin II Receptor Antagonism Reduces Insulin Resistance in Obese Zucker Rats

  2001cites this paper
• Angiotensin II type-1 receptor antagonist, CS-866, reduces blood pressure without affecting glucose/insulin metabolism in cholesterol-fed rabbits.

  2001cites this paper
• Modulation of tumor necrosis factor-α production with anti-hypertensive drugs

  2000cites this paper
• Clinical Trials: The HOPE Trial.

  2000cites this paper
• Modulation of tumor necrosis factor-alpha production with anti-hypertensive drugs.

  2000cites this paper
• The HOPE Trial

  2000cites this paper
• Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension

  2000cites this paper
• Efficacy and Safety of Quinapril 40mg Once Daily as Monotherapy for Patients with Poorly Controlled Hypertension

  2000cites this paper
• Trandolapril does not improve insulin sensitivity in patients with hypertension and type 2 diabetes: a double-blind, placebo-controlled crossover trial.

  2000cites this paper
• The relationship between risk of hypoglycemia and use of cibenzoline and disopyramide

  2000cites this paper
• Endocrinology of Aging

  2000cites this paper
• Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasosartan Investigators Group.

  1999cites this paper
• Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2.

  1999cites this paper
• ACE inhibition and glucose transport in insulinresistant muscle: roles of bradykinin and nitric oxide.

  1999cites this paper
• rapid communication ACE inhibition and glucose transport in insulin-resistant muscle : roles of bradykinin and nitric oxide

  1999cites this paper
• HYPERLIPIDAEMIA AND THE PROGRESSION OF NEPHROPATHY IN OLETF RATS: EFFECT OF ANGIOTENSIN‐CONVERTING ENZYME INHIBITOR, ENALAPRIL

  1999cites this paper
• Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat.

  1999cites this paper
• The Metabolic Syndrome

  1999cites this paper
• Effects of quinapril and losartan on insulin sensitivity in genetic hypertensive rats with different metabolic abnormalities.

  1999cites this paper
• 10 INSULIN RESISTANCE, AND HYPERTENSION

  1999cites this paper
• Insulin Resistance, and Hypertension

  1999cites this paper
• Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension.

  1999cites this paper
• The mechanisms of insulin sensitivity improving effects of angiotensin converting enzyme inhibitor.

  1999cites this paper
• Obesity and hypertension: from pathophysiology to treatment

  1999cites this paper
• イワシタンパク質由来ペプチドならびに Valyl-Tyrosine の降圧作用-高血圧自然発症ラットに対する効果-

  1999cites this paper
• Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: Results from a 10-week, double-blind, placebo-controlled, dose-titration study

  1999cites this paper
• Personal viewpoint: new developments in the therapy of diabetic hypertensive disease. The ABCD study adds to strong evidence favoring the prime use of ACE inhibitors. Appropriate Blood Pressure Control in Diabetes.

  1998cites this paper
• Contribution of bradykinin to the beneficial effects of ramipril in the fructose-fed rat.

  1998cites this paper
• Effects of the angiotensin converting enzyme inhibitor temocapril on insulin sensitivity and its effects on renal sodium handling and the pressor system in essential hypertensive patients.

  1998cites this paper
• Long-term effects of perindopril on metabolic parameters and the heart in the spontaneously hypertensive/NIH-corpulent rat with non-insulin-dependent diabetes mellitus and hypertension.

  1998cites this paper
• Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients.

  1998cites this paper
• Effect of chronic bradykinin administration on insulin action in an animal model of insulin resistance.

  1998cites this paper
• Effect of the Vasodilatory β-Blocker, Nipradilol, and Ca-Antagonist, Barnidipine, on Insulin Sensitivity in Patients with Essential Hypertension

  1998cites this paper
• Effects of angiotensin II-receptor blockade with losartan on insulin sensitivity, lipid profile, and endothelin in normotensive offspring of hypertensive parents.

  1998cites this paper
• Effect of the vasodilatory beta-blocker, nipradilol, and Ca-antagonist, barnidipine, on insulin sensitivity in patients with essential hypertension.

  1998cites this paper
• Interactions of exercise training and ACE inhibition on insulin action in obese Zucker rats.

  1998cites this paper
• Tissue availability of insulin‐like growth factor I is inversely related to insulin resistance in essential hypertension: effects of angiotensin converting enzyme inhibition

  1998cites this paper
• Effect of chronic bradykinin administration on insulin action in an animal model of insulin resistance.

  1998cites this paper
• Personal Viewpoint: New Developments in the Therapy of Diabetic Hypertensive Disease. The ABCD Study Adds to Strong Evidence Favoring the Prime Use of ACE Inhibitors

  1998cites this paper